Use access key #2 to skip to page content.
$14.38 2.08 (16.91%)
10/13/2008 4:00 PM

Amylin Pharmaceuticals, Inc. (AMLN)

CAPS Rating:
**

A biopharmaceutical company committed to improving the lives of people with diabetes, obesity and other diseases through the discovery, development and commercialization of innovative medicines.

View All Commentary (AMLN)

Recs

0

Avatar maktop (42.39) Submitted: 1/26/07 12:08 PM : Outperform Start Price: $38.68 AMLN Score: -33.15

Diabetic drug that works very well and diabetes is at epidemic proportions in the population

Report this Post Replies: 0 | Reply

Featured Broker Partners